Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bovine lactoferrin is effective in
preventing and curing iron deficiency and iron deficiency anemia in Hereditary Thrombophilia
affected women during pregnancy.
The proposed clinical trial is considered as PHASE IV because in Italy bLf is commercialized
by Grunenthal, as Lattoglobina® (capsules with 100 mg of bLf), to prevent and cure iron
deficiency and iron deficiency anemia in pregnant women.